H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 8.6% of adults in Boston have diagnosed diabetes — 3.4 points below the U.S. 12% figure. Census population 675,647. Massachusetts Medicare wound biologics: National Government Services (NGS) (JK). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Boston clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Boston storefront.
Collagen Wound Care Products for Healthcare Providers in Boston, MA for clinics & physicians. Compliance support & pricing — contact Hawk Medical.
Two files matter before you open a box of collagen wound care in Boston: (1) CDC PLACES (2023, crude) estimates 8.6% of adults in Boston have diagnosed diabetes — 3.4 points below the U.S. 12% figure. (2) Massachusetts Part B wound biologics are reviewed by National Government Services (NGS) under JK, shared with CT, ME, NH, NY, RI, VT. We help with the second file. We do not pretend to be a Boston storefront.
National Collagen Wound Care Products for Healthcare Providers notes (how the product actually works)6.3% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. A city of 500k–1M with 675,647 residents will still mix those payers. CDC PLACES (2023, crude) estimates 8.6% of adults in Boston have diagnosed diabetes — 3.4 points below the U.S. 12% figure. Build two utilization policies if you do both cash PRP and Medicare CTPs.
The 96.5% hematogel figure on our wound materials is product-level clinical experience, not a Boston trial. Local outcomes stay with the treating physician. CDC PLACES (2023, crude) estimates 8.6% of adults in Boston have diagnosed diabetes — 3.4 points below the U.S. 12% figure. Use that rate for inventory math, not for ads.
CDC PLACES (2023, crude prevalence) estimates 8.6% of adults — 3.4 points below the U.S. 12% figure. Obesity is 23.4%; arthritis is 17.8%. That is place-level BRFSS modeling, not a clinic census and not a Boston trial.
No. Hawk Medical does not distribute products as “stem cell therapy.” HCT/P 361 allografts are regulated under 21 CFR 1271 for homologous use and minimal manipulation. PRP is autologous. Marketing that blurs those lanes is a compliance problem in every state, including Massachusetts.
No. PRP (autologous) and cellular/tissue products (allograft/skin substitutes) sit on different coding and coverage paths. National Government Services (NGS) LCDs for CTPs do not automatically cover PRP injections. Build separate protocols and fee tickets.
Use the contact form or book a 15-minute call with Joe Bradley. Bring specialty, monthly wound or joint volume, and whether you bill JK FFS, Advantage, workers’ comp, or cash-pay.
Bring specialty, monthly wound volume, and whether you bill JK FFS, Advantage, workers’ comp, or cash-pay. We already have PLACES 8.6% diabetes and 17.8% arthritis for Boston — tell us how that matches your panel. Book 15 minutes with Joe or use the contact form.
Contact us to learn how Hawk Medical supports practices in Boston, MA.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Boston is JK geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Boston — 3.4 points below the U.S. 12% figure. Planning input, not an outcomes claim.
Massachusetts Part B wound biologics follow this contractor (siblings: CT, ME, NH, NY, RI, VT). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Boston. Useful for joint-program math; still needs a diagnosis and privileging.
No Boston storefront. Joe Bradley is an active practice owner. collagen wound care stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.